Therapeutic Vaccines for Hypertension: a New Option for Clinical Practice

Angiotensin II Peptide Vaccine Protects Ischemic Brain Through Reducing Oxidative Stress

(2017) Kouji Wakayama et al.   STROKE

A peptide vaccine targeting angiotensin II attenuates the cardiac dysfunction induced by myocardial infarction

(2017) Ryo Watanabe et al.   Scientific Reports

Decrease in Blood Pressure and Regression of Cardiovascular Complications by Angiotensin II Vaccine in Mice

(2013) Futoshi Nakagami et al.   PLoS One

Effectiveness and Safety of a Therapeutic Vaccine Against Angiotensin II Receptor Type 1 in Hypertensive Animals

(2012) Xiao Chen et al.   HYPERTENSION

Vaccination against the angiotensin type 1 receptor for the prevention of L-NAME-induced nephropathy

(2011) Tatsuhiko Azegami et al.   HYPERTENSION RESEARCH

Medication Adherence: WHO Cares?

(2011) Marie T. Brown et al.   MAYO CLINIC PROCEEDINGS

Vaccines in the management of hypertension

(2010) Thong Huy Do et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Effect of immunisation against angiotensin II with CYT006-AngQb on ambulatory blood pressure: a double-blind, randomised, placebo-controlled phase IIa study

(2008) Alain C Tissot et al.   LANCET